Printing Paradigms

Bioprinting ◽  
2021 ◽  
pp. 3-20
Author(s):  
Kenneth Douglas

Abstract: This chapter introduces the invention of 3D printing in the mid-1980s and discusses how bioprinting emerged from that technology some 15 years later, the significantly more formidable requirements that bioprinting presents compared to 3D printing, and the scientists who were the trailblazers of bioprinting. Mention is made of several medical successes of 3D printing prior to the advent of bioprinting. The chapter describes three of the principal bioprinting techniques and the steps that comprise the fundamental process regardless of the specific technique employed. It provides an introduction to some of the basic lexicon of bioprinting—words such as bioinks, bioreactors, extracellular matrices, rheology, and scaffolds. The chapter acquaints the reader with new and novel developments such as the Kenzan method style of bioprinting as well as the innovation of rotational 3D printing and its possible use in bioprinting.

2021 ◽  
Vol 8 (10) ◽  
pp. 133
Author(s):  
Foteini K. Kozaniti ◽  
Despoina Nektaria Metsiou ◽  
Aikaterini E. Manara ◽  
George Athanassiou ◽  
Despina D. Deligianni

Recent decades have seen a plethora of regenerating new tissues in order to treat a multitude of cardiovascular diseases. Autografts, xenografts and bioengineered extracellular matrices have been employed in this endeavor. However, current limitations of xenografts and exogenous scaffolds to acquire sustainable cell viability, anti-inflammatory and non-cytotoxic effects with anti-thrombogenic properties underline the requirement for alternative bioengineered scaffolds. Herein, we sought to encompass the methods of biofabricated scaffolds via 3D printing and bioprinting, the biomaterials and bioinks recruited to create biomimicked tissues of cardiac valves and vascular networks. Experimental and computational designing approaches have also been included. Moreover, the in vivo applications of the latest studies on the treatment of cardiovascular diseases have been compiled and rigorously discussed.


Author(s):  
Robert Williams ◽  
Che-Hung Lee ◽  
Sara E. Quella ◽  
David M. Harlan ◽  
Yuan-Hsu Kang

Monocyte adherence to endothelial or extracellular matrices plays an important role in triggering monocyte activation in extravascular sites of infection, chronic inflammatory disorders, and tissue damage. Migration of monocytes in the tissues involves the response to a chemoattractant and movement by a series of attachments and detachments to the extracellular matrices which are regulated by expression and distribution of specific receptors for the matrix proteins such as fibronectin (FN). The VSAs (very late antigens or beta integrins), a subfamily of the transmembrane heterodimeric integrin receptors, have been thought to play a major role in monocyte adherence to the extracellular matrices and cells. In this subfamily, VLA-5 and VLA-4 are believed to be the most essential integrins mediating monocyte adherence to FN. In the present report, we have established and compared different procedures for morphological evaluation of the expression and distribution of the FN receptors on human monocytes in order to investigate their response to endotoxin or cytokine stimulation.


2019 ◽  
Vol 63 (5) ◽  
pp. 579-594 ◽  
Author(s):  
Guillem Lambies ◽  
Antonio García de Herreros ◽  
Víctor M. Díaz

Abstract Cell migration is a multifactorial/multistep process that requires the concerted action of growth and transcriptional factors, motor proteins, extracellular matrix remodeling and proteases. In this review, we focus on the role of transcription factors modulating Epithelial-to-Mesenchymal Transition (EMT-TFs), a fundamental process supporting both physiological and pathological cell migration. These EMT-TFs (Snail1/2, Twist1/2 and Zeb1/2) are labile proteins which should be stabilized to initiate EMT and provide full migratory and invasive properties. We present here a family of enzymes, the deubiquitinases (DUBs) which have a crucial role in counteracting polyubiquitination and proteasomal degradation of EMT-TFs after their induction by TGFβ, inflammatory cytokines and hypoxia. We also describe the DUBs promoting the stabilization of Smads, TGFβ receptors and other key proteins involved in transduction pathways controlling EMT.


Nature ◽  
2013 ◽  
Vol 494 (7436) ◽  
pp. 174-174 ◽  
Author(s):  
Michael Pawlyn
Keyword(s):  

Nature ◽  
2020 ◽  
Vol 588 (7839) ◽  
pp. 594-595
Author(s):  
Cameron Darkes-Burkey ◽  
Robert F. Shepherd
Keyword(s):  

Author(s):  
Thomas Birtchnell ◽  
William Hoyle
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document